Prospective evaluation of follow-up in melanoma patients in Germany - Results of a multicentre and longitudinal study

European Journal of Cancer

Volumn 51, Issue 5, 2015, Pages 653-667

  Livingstone, E ^a   Krajewski, C ^a   Eigentler, T K ^b   Windemuth Kieselbach, C ^c   Benson, S ^a   Elsenbruch, S ^a   Hauschild, A ^d   Rompel, R ^e   Meiss, F ^f   Mauerer, A ^g   Kahler K C ^d   Dippel, E ^h   Mollenhoff K ⁱ   Kilian, K ^j   Mohr, P ^k   Utikal, J ^l,m   Schadendorf, D ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c ALCEDIS GMBH   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e Clinical Center of Kassel   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITY OF REGENSBURG   (Germany)

^h Clinical Center of Ludwigshafen   (Germany)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^k Am Krankenhaus 1   (Germany)

^l GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^m UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

Cost effectiveness; Costs; Follow up; Guideline; Melanoma; Patient education; Psychosocial support; Recurrence; Surveillance

Indexed keywords

ADULT; ANXIETY; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; COMORBIDITY; COPING BEHAVIOR; COST EFFECTIVENESS ANALYSIS; DEPRESSION; FEMALE; FOLLOW UP; GERMANY; HEALTH CARE COST; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSOCIAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; AGED; ATTITUDE TO HEALTH; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE COURSE; EARLY DIAGNOSIS; HEALTH CARE DISPARITY; LONG TERM CARE; MIDDLE AGED; MULTICENTER STUDY; ONCOLOGY; PATHOLOGY; PREDICTIVE VALUE; PSYCHOLOGY; RISK ASSESSMENT; RISK FACTOR; SECONDARY; SELF EXAMINATION; SKIN NEOPLASMS; SOCIAL SUPPORT; STANDARDS; TIME; TREATMENT OUTCOME;

ADULT; AGED; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; GERMANY; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHCARE DISPARITIES; HUMANS; LONG-TERM CARE; LONGITUDINAL STUDIES; MALE; MEDICAL ONCOLOGY; MELANOMA; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SELF-EXAMINATION; SKIN NEOPLASMS; SOCIAL SUPPORT; TIME FACTORS; TREATMENT OUTCOME;

EID: 84924351142     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.01.007     Document Type: Article

References (56)

1. Z.V. Fong, and K.K. Tanabe Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review Br J Dermatol 170 2014 20 30
2. C.M. Balch, J.E. Gershenwald, and S.J. Soong Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
3. Party ACNMGRW. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Available from URL: http://www.nhmrc.gov.au/-files-nhmrc/file/publications/synopses/cp111.pdf.
4. A. Pflugfelder, C. Kochs, A. Blum, et al. Malignant melanoma S3-guideline "Diagnosis, Therapy and Follow-up of Melanoma" J Dtsch Dermatol Ges 11 Suppl. 6 2013 1 116
5. R. Dummer, R. Panizzon, P.H. Bloch, and G. Burg Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma Dermatology 210 2005 39 44
6. Network NCC. NCCN clinical practice guidelines in oncology: melanoma. Available from URL: http://www.nccn.org/professionals/physician-gls/pdf/melanoma.pdf.
7. C.K. Bichakjian, A.C. Halpern, T.M. Johnson, et al. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology J Am Acad Dermatol 65 2011 1032 1047
8. U. Leiter, P.G. Buettner, T.K. Eigentler, et al. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry J Am Acad Dermatol 66 2012 37 45
9. Robert-Koch-Institut. Krebs in Deutschland 2007/2008. Berlin: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., 2012.
10. W.J. Poo-Hwu, S. Ariyan, and L. Lamb Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma Cancer 86 1999 2252 2258
11. C. Garbe Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy J Clin Oncol 21 2003 520 529
12. A. Francken, E. Bastiaannet, and H. Hoekstra Follow-up in patients with localised primary cutaneous melanoma Lancet Oncol 6 2005 608 621
13. A.B. Francken, N.A. Accortt, and H.M. Shaw Follow-up schedules after treatment for malignant melanoma Br J Surg 95 2008 1401 1407
14. R.M. Turner, K.J. Bell, R.L. Morton, et al. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma J Clin Oncol 29 2011 4641 4646
15. U. Hofmann, M. Szedlak, W. Rittgen, E.G. Jung, and D. Schadendorf Primary staging and follow-up in melanoma patients - monocenter evaluation of methods, costs and patient survival Br J Cancer 87 2002 151 157
16. U.R. Hengge, A. Wallerand, A. Stutzki, and N. Kockel Cost-effectiveness of reduced follow-up in malignant melanoma J Dtsch Dermatol Ges 5 2007 898 907
17. M.O. Meyers, J.J. Yeh, J. Frank, et al. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging Ann Surg Oncol 16 2009 941 947
18. F.A. Kalimullah, and C.W. Brown Compliance with follow-up among patients with melanoma and non-melanoma skin cancers Dermatol Online J 20 2014
19. C. Holterhues, L.V. van de Poll-Franse, E. de Vries, H.A. Neumann, and T.E. Nijsten Melanoma patients receive more follow-up care than current guideline recommendations: a study of 546 patients from the general Dutch population J Eur Acad Dermatol Venereol 26 2012 1389 1395
20. A. Testori, V. Chiarion-Sileni, I. Stanganelli, et al. Follow-up of melanoma: a survey of Italian hospitals Dermatology 226 Suppl. 1 2013 32 38
21. S.C. Trotter, N. Sroa, R.R. Winkelmann, T. Olencki, and M. Brechtel A global review of melanoma follow-up guidelines J Clin Aesthet Dermatol 6 2013 18 26
22. K.D. Cromwell, M.I. Ross, Y. Xing, et al. Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review Melanoma Res 22 2012 376 385
23. C. Garbe, D. Schadendorf, W. Stolz, et al. Short German guidelines: malignant melanoma J Dtsch Dermatol Ges 6 Suppl. 1 2008 S9 S14
24. E. Livingstone, C. Windemuth-Kieselbach, T.K. Eigentler, et al. A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up Eur J Cancer 47 2011 1977 1989
25. N.K. Aaronson, S. Ahmedzai, B. Bergman, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
26. C. Herrmann International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results J Psychosom Res 42 1997 17 41
27. A.S. Zigmond, and R.P. Snaith The hospital anxiety and depression scale Acta Psychiatr Scand 67 1983 361 370
28. A. Hinz, O. Krauss, J.P. Hauss, et al. Anxiety and depression in cancer patients compared with the general population Eur J Cancer Care (Engl) 19 2010 522 529
29. A. Hinz, and E. Brahler Normative values for the hospital anxiety and depression scale (HADS) in the general German population J Psychosom Res 71 2011 74 78
30. Department EQoL. EORTC QLQ-C30 Reference Values Available from URL: http://groups.eortc.be/qol/sites/default/files/img/newsletter/reference-values-manual2008.pdf.
31. T.J. Dicker, G.M. Kavanagh, R.M. Herd, et al. A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group Br J Dermatol 140 1999 249 254
32. A.B. Francken, H.M. Shaw, N.A. Accortt, S.J. Soong, H.J. Hoekstra, and J.F. Thompson Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines Ann Surg Oncol 14 2007 1924 1933
33. A.M. Hohnheiser, O. Gefeller, J. Gohl, G. Schuler, W. Hohenberger, and S. Merkel Malignant melanoma of the skin: long-term follow-up and time to first recurrence World J Surg 35 2011 580 589
34. U. Leiter, A.A. Marghoob, K. Lasithiotakis, et al. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma Melanoma Res 19 2009 50 57
35. M.M. Mooney, M. Kulas, B. McKinley, A.M. Michalek, and W.G. Kraybill Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma Ann Surg Oncol 5 1998 54 63
36. C.A. Baughan, V.L. Hall, B.J. Leppard, and P.J. Perkins Follow-up in stage I cutaneous malignant melanoma: an audit Clin Oncol (R Coll Radiol) 5 1993 174 180
37. N.A. Kasparian, R. Branstrom, Y.M. Chang, et al. Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination Arch Dermatol 148 2012 1142 1151
38. G.S. Mijnhout, G.J. Teule, O.S. Hoekstra, R. Pijpers, P.J. Borgstein, and S. Meijer Follow-up after melanoma resection is more extensive than recommended in the practice guidelines, primarily for reassurance of the patient Ned Tijdschr Geneeskd 143 1999 997 1001
39. M. Gibertini, D.S. Reintgen, and W.F. Baile Psychosocial aspects of melanoma Ann Plast Surg 28 1992 17 21
40. P.C. Trask, A.G. Paterson, S. Hayasaka, R.L. Dunn, M. Riba, and T. Johnson Psychosocial characteristics of individuals with non-stage IV melanoma J Clin Oncol 19 2001 2844 2850
41. J. Zabora, K. BrintzenhofeSzoc, B. Curbow, C. Hooker, and S. Piantadosi The prevalence of psychological distress by cancer site Psychooncology 10 2001 19 28
42. N.A. Kasparian Psychological stress and melanoma: are we meeting our patients' psychological needs? Clin Dermatol 31 2013 41 46
43. D.A. Boyle Psychological adjustment to the melanoma experience Semin Oncol Nurs 19 2003 70 77
44. D. Spiegel Cancer and depression Br J Psychiatry Suppl 1996 109 116
45. M.R. DiMatteo, H.S. Lepper, and T.W. Croghan Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence Arch Intern Med 160 2000 2101 2107
46. P.N. Butow, A.S. Coates, and S.M. Dunn Psychosocial predictors of survival in metastatic melanoma J Clin Oncol 17 1999 2256 2263
47. W.G. Manning Jr., and K.B. Wells The effects of psychological distress and psychological well-being on use of medical services Med Care 30 1992 541 553
48. G. Simon, J. Ormel, M. VonKorff, and W. Barlow Health care costs associated with depressive and anxiety disorders in primary care Am J Psych 152 1995 352 357
49. H. Kittler, R. Weitzdorfer, H. Pehamberger, K. Wolff, and M. Binder Compliance with follow-up and prognosis among patients with thin melanomas Eur J Cancer 37 2001 1504 1509
50. D. Osoba, G. Rodrigues, J. Myles, B. Zee, and J. Pater Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16 1998 139 144
51. E.G. Eakin, D.R. Youlden, P.D. Baade, et al. Health status of long-term cancer survivors: results from an Australian population-based sample Cancer Epidemiol Biomarkers Prev 15 2006 1969 1976
52. R. Sanson-Fisher, A. Girgis, A. Boyes, B. Bonevski, L. Burton, and P. Cook The unmet supportive care needs of patients with cancer. Supportive Care Review Group Cancer 88 2000 226 237
53. L.J. Fallowfield, A. Hall, P. Maguire, M. Baum, and R.P. A'Hern Psychological effects of being offered choice of surgery for breast cancer BMJ 309 1994 448
54. S.E. Thorne, B.D. Bultz, W.F. Baile, and S.C. Team Is there a cost to poor communication in cancer care? A critical review of the literature Psychooncology 14 2005 875 884 [discussion 885-876]
55. P.E. Schofield, P.N. Butow, J.F. Thompson, M.H. Tattersall, L.J. Beeney, and S.M. Dunn Psychological responses of patients receiving a diagnosis of cancer Ann Oncol 14 2003 48 56
56. E.L. Korn, P.Y. Liu, S.J. Lee, et al. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials J Clin Oncol 26 2008 527 534